Cipla

Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in

R Amin05 mins mins

For Indian pharmaceutical exports, the US represents the primary market, comprising about 35% of total exports, with a value reaching about $10 billion in FY25. (AI image) US President Donald Trump’s move to impose 100% tariffs on branded and patented pharmaceutical exports has rattled Indian pharma stocks, even though most companies earn from US markets…

Read More

Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street

R Amin02 mins mins

Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% tariffs…

Read More